TY - JOUR
T1 - Validation of a screening tool for autism spectrum disorder in adults - a study protocol
AU - Parvaiz, Rizwan
AU - Al-Sayegh, Zainab
AU - Jacobsen, Peter Kristian
AU - Danielsen, Ida-Marie
AU - Videbech, Poul
N1 - Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
PY - 2022/11/23
Y1 - 2022/11/23
N2 - INTRODUCTION. Autism spectrum disorder (ASD) in adults is exhibiting an increase in prevalence, and a growing rate of referrals is observed from primary health professionals to specialised units. The heterogeneous clinical presentation and high prevalence of comorbidity seen in ASD challenges the case identification, emphasising the need for screening tools with a high validity and reliability. Previously, satisfactory psychometric properties of the Ritvo Autism Asperger Diagnostic Scale – Revised (RAADS-R) have been demonstrated, and it is a widely used screening tool in Denmark. Nevertheless, a validation of a Danish version of the RAADS-R has not been performed in a Danish population. To evaluate its clinical relevance, we aim to test the psychometric properties of a Danish translation of the RAADS-R (RAADS-R-DK) in an adult population. METHODS. We aim to test 200 ASD patients, 200 non-ASD psychiatric patients and 200 healthy controls. The results from the RAADS-R will be compared with the clinical diagnoses from interdisciplinary teams at specialised outpatient clinics. CONCLUSION. The aim of the study is to investigate the validity, reliability and clinical features of the RAADS-R-DK. FUNDING. Mental Health Center Glostrup and Trygfonden. TRIAL REGISTRATION. ClinicalTrials.gov NCT05213286.
AB - INTRODUCTION. Autism spectrum disorder (ASD) in adults is exhibiting an increase in prevalence, and a growing rate of referrals is observed from primary health professionals to specialised units. The heterogeneous clinical presentation and high prevalence of comorbidity seen in ASD challenges the case identification, emphasising the need for screening tools with a high validity and reliability. Previously, satisfactory psychometric properties of the Ritvo Autism Asperger Diagnostic Scale – Revised (RAADS-R) have been demonstrated, and it is a widely used screening tool in Denmark. Nevertheless, a validation of a Danish version of the RAADS-R has not been performed in a Danish population. To evaluate its clinical relevance, we aim to test the psychometric properties of a Danish translation of the RAADS-R (RAADS-R-DK) in an adult population. METHODS. We aim to test 200 ASD patients, 200 non-ASD psychiatric patients and 200 healthy controls. The results from the RAADS-R will be compared with the clinical diagnoses from interdisciplinary teams at specialised outpatient clinics. CONCLUSION. The aim of the study is to investigate the validity, reliability and clinical features of the RAADS-R-DK. FUNDING. Mental Health Center Glostrup and Trygfonden. TRIAL REGISTRATION. ClinicalTrials.gov NCT05213286.
KW - Adult
KW - Humans
KW - Ambulatory Care Facilities
KW - Autism Spectrum Disorder/diagnosis
KW - Psychometrics
KW - Referral and Consultation
KW - Reproducibility of Results
KW - Healthy Volunteers
KW - Health Sciences
UR - https://www.scopus.com/pages/publications/85143185870
M3 - Journal article
C2 - 36458608
SN - 0907-8916
VL - 69
JO - Danish Medical Bulletin
JF - Danish Medical Bulletin
IS - 12
M1 - A02220118
ER -